The U.S. Department of Health & Human Services, through its National Center for HIV/AIDS, awarded a $129,005,015 Cooperative Agreement to the New York City Department of Health and Mental Hygiene (Health Dept) under the HIV Prevention Activities Health Department Based (CFDA 93.940) program. This 5-year grant, effective August 1, 2024, will support the Health Dept's comprehensive and integrated HIV surveillance and prevention program to achieve the national Ending the HIV Epidemic (EHE) goal...
This $1,800,000 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) HIV Prevention Activities Health Department Based program (CFDA 93.940) will enable New York City Health and Hospitals Corporation (NYCHHC) to strengthen sexual health infrastructure and service delivery for priority populations in New York City. The key products and services to be delivered include: 1) Expanding existing sexual health services to develop two express model sexual health...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a 5-year, $35,695,253 Cooperative Agreement under CFDA 93.939 (HIV Prevention Activities Non-Governmental Organization Based) to the North Carolina Department of Health & Human Services (NC DHHS). The purpose of the award is to increase knowledge of HIV status, rapid linkage to care and viral suppression, and prevent HIV transmission through a multi-pronged approach. Key activities include PrEP, harm reduction, traditional and...
This $59,329,115 five-year Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) supports the Georgia Department of Public Health's (DPH) comprehensive, person-centered HIV prevention and surveillance program. The award will fund activities to diagnose people with HIV as early as possible, rapidly treat them to achieve viral suppression, prevent new HIV transmissions,...
The Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 Cooperative Agreement under the "Capacity Building Assistance (CBA) for High-Impact HIV Prevention" program (CFDA 93.834) to Public Health Foundation Enterprises, Inc. (doing business as Heluna Health), a non-profit organization. The award, with a performance period from August 2024 to March 2029, will support Heluna Health in providing technical assistance, training, and organizational development services to...
The Hawaii Department of Health (HDOH) was awarded a $2,972,090 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The funding will support HDOH's efforts to improve Hawaii's HIV prevention and surveillance system through strategies to: 1) increase HIV status knowledge to 95%, 2) rapidly link individuals to HIV care and achieve 95% viral suppression, 3) expand PrEP and...
This Cooperative Agreement award from the National Center for HIV/AIDS at the Centers for Disease Control and Prevention (CDC) under CFDA 93.940 - HIV Prevention Activities Health Department Based provides $34,362,657 to the Massachusetts Department of Public Health (MDPH) to implement high-impact HIV prevention, surveillance, and health equity strategies across the Commonwealth. The key products and services to be delivered through this 5-year award include: increasing HIV testing and linkage...
The Maine Department of Health and Human Services, Center for Disease Control and Prevention (Maine CDC) received a $3,630,584 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The funding will support HIV prevention and surveillance activities to improve the HIV care continuum in Maine. Specifically, the award will fund strategies such as HIV testing, case...
This federal Project Grant award of $1,570,976.00 from the Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the HIV Care Formula Grants program (CFDA 93.917) will support comprehensive HIV/AIDS healthcare services provided by Health Research, Inc.'s Aids Institute Division in Albany, New York. The funding will enable Health Research, Inc. to improve the quality, availability, and organization of a continuum of high-quality medical and...
The Virgin Islands Department of Health Group was awarded a $3,049,859 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The award, effective August 1, 2024 through May 31, 2029, will support comprehensive efforts to prevent, diagnose, and manage HIV in the U.S. Virgin Islands. Key strategies include enhancing HIV surveillance, increasing testing and awareness, improving access to...